Lv21
168 积分 2023-08-06 加入
Cancer statistics, 2025
4小时前
待确认
Diffusion MRI is valuable in brainstem glioma genotyping with quantitative measurements of white matter tracts
15天前
已完结
Preoperative Controlling Nutritional Status (CONUT) Score for Assessment of Prognosis Following Hepatectomy for Hepatocellular Carcinoma
23天前
已完结
Biomarkers of hepatocellular carcinoma: status and prospects
1个月前
已关闭
Combinations of lenvatinib and immune checkpoint inhibitors plus transarterial chemoembolization, is it the prime time for unresectable hepatocellular carcinoma?
3个月前
已完结
The CRAFITY score emerges as a paramount prognostic indicator in hepatocellular carcinoma patients received Lenvatinib and Pembrolizumab
4个月前
已完结
Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study
5个月前
已完结
Dichotomizing continuous predictors in multiple regression: a bad idea
5个月前
已完结
“Six-and-twelve” score for outcome prediction of hepatocellular carcinoma following transarterial chemoembolization. In-depth analysis from a multicenter French cohort
5个月前
已完结
Validation of the “Six-and-Twelve” Prognostic Score in Transarterial Chemoembolization–Treated Hepatocellular Carcinoma Patients
5个月前
已完结
皖公网安备34019202002308
